Therapeutic interchange involving replacement of rofecoxib or celecoxib with valdecoxib

Am J Health Syst Pharm. 2004 Jul 1;61(13):1391-4. doi: 10.1093/ajhp/61.13.1391.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Arthritis, Rheumatoid / drug therapy
  • Celecoxib
  • Chronic Disease
  • Cost Savings
  • Cyclooxygenase 2
  • Drug Utilization Review
  • Endpoint Determination
  • Female
  • Hospitals, Veterans
  • Humans
  • Isoenzymes / antagonists & inhibitors*
  • Isoxazoles / economics
  • Isoxazoles / pharmacokinetics
  • Isoxazoles / therapeutic use*
  • Lactones / economics
  • Lactones / pharmacokinetics
  • Lactones / therapeutic use*
  • Male
  • Membrane Proteins
  • Osteoarthritis / drug therapy
  • Pain / drug therapy
  • Prostaglandin-Endoperoxide Synthases
  • Pyrazoles
  • Sulfonamides / economics
  • Sulfonamides / pharmacokinetics
  • Sulfonamides / therapeutic use*
  • Sulfones
  • Therapeutic Equivalency

Substances

  • Isoenzymes
  • Isoxazoles
  • Lactones
  • Membrane Proteins
  • Pyrazoles
  • Sulfonamides
  • Sulfones
  • rofecoxib
  • valdecoxib
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Celecoxib